"Das Kantonsspital Aarau (KSA) ist das grösste Spital des Kantons Aargau und neben den Universitätsspitälern eines der grössten Zentrumsspitäler der Schweiz. Die Allgemeine Innere Medizin des KSA trägt seit 2010 den Status einer universitären Klinik. Als überregionales Gesundheitszentrum mit ausserkantonaler Ausstrahlung verfügt das KSA über eine erstklassige medizinisch-technische Infrastruktur, betreibt eine rege Forschungstätigkeit und ist eine bedeutende Weiterbildungsstätte für angehende Fachärzte sowie ein attraktiver Arbeitgeber für zahlreiche Berufsgruppen aus Pflege, Therapie und Betrieb."

During the past decade, Dept. of Neurology, Kantonsspital Aarau conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dept. of Neurology, Kantonsspital Aarau" #1 collaborator was "Swiss National Science Foundation" with 2 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dept. of Neurology, Kantonsspital Aarau" are "Ischaemic Stroke" (1 trials), "Ischemic Stroke" (1 trials), "Stroke, Acute" (1 trials) and "Stroke, Ischemic" (1 trials). Many other conditions were trialed in "Dept. of Neurology, Kantonsspital Aarau" in a lesser frequency.

Most popular intervention types in "Dept. of Neurology, Kantonsspital Aarau" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Aspirin" (1 trials), "Clopidogrel" (1 trials), "Dabigatran" (1 trials) and "Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept. of Neurology, Kantonsspital Aarau" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Dept. of Neurology, Kantonsspital Aarau". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dept. of Neurology, Kantonsspital Aarau, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dept. of Neurology, Kantonsspital Aarau, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".